Based on the National Research Corp stock forecast from 0 analysts, the average analyst target price for National Research Corp is not available over the next 12 months. National Research Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of National Research Corp is Neutral, which is based on 9 positive signals and 8 negative signals. At the last closing, National Research Corp’s stock price was USD 10.63. National Research Corp’s stock price has changed by +0.95% over the past week, -26.39% over the past month and -68.95% over the last year.
No recent analyst target price found for National Research Corp
No recent average analyst rating found for National Research Corp
Company Overview National Research Corp
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. Read Less
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range ...Read More
Frequently Asked Questions About National Research Corp (NRC) Stock
Stock Target Advisor's fundamental analysis for National Research Corp's stock is Neutral.
NRC stock's dividend yield is 4.49%.
Our analysis grades NRC stock's dividend yield at F. This means that NRC stock's dividend yield is above 50% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this NRC may be a average dividend stock for its sector.
Unfortunately we do not have enough data on NRC's stock to indicate what its average analyst target is.
NRC stock's Price/Earning ratio is 10.29.
Our analysis grades NRC stock's Price / Earning ratio at A-. This means that NRC stock's Price/Earning ratio is above 7.999999999999996% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this NRC may be undervalued for its sector.
The last closing price of NRC's stock was USD 10.63.
The most recent market capitalization for NRC is USD 0.24B.
Unfortunately we do not have enough analyst data on NRC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains National Research Corp's stock.
As per our most recent records National Research Corp has 368 Employees.
National Research Corp's registered address is 1245 Q Street, Lincoln, NE, United States, 68508.
You can get more information about it from National Research Corp's website at https://www.nrchealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About National Research Corp (NRC) Stock
Stock Target Advisor's fundamental analysis for National Research Corp's stock is Neutral.
NRC stock's dividend yield is 4.49%.
Our analysis grades NRC stock's dividend yield at F. This means that NRC stock's dividend yield is above 50% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this NRC may be a average dividend stock for its sector.
Unfortunately we do not have enough data on NRC's stock to indicate what its average analyst target is.
NRC stock's Price/Earning ratio is 10.29.
Our analysis grades NRC stock's Price / Earning ratio at A-. This means that NRC stock's Price/Earning ratio is above 7.999999999999996% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this NRC may be undervalued for its sector.
The last closing price of NRC's stock was USD 10.63.
The most recent market capitalization for NRC is USD 0.24B.
Unfortunately we do not have enough analyst data on NRC's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains National Research Corp's stock.
As per our most recent records National Research Corp has 368 Employees.
National Research Corp's registered address is 1245 Q Street, Lincoln, NE, United States, 68508.
You can get more information about it from National Research Corp's website at https://www.nrchealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NRC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
